Sciele, the current manufacturer of the calcium-channel blocker Sular (nisoldipine) has completed the transition to their new tablet formulation and strengths.
UK company SkyePharma’s GeoMatrix technology has been used to develop a new formulation of a hypertension drug which can provide lower drug doses.
The new formulation of Sciele Pharma’s Sular (nisoldipine), a calcium channel blocking agent […]

The Food and Drug Administration has approved the following Zaleplon (generic for King’s Sonata) from Roxane, Genpharm, Teva, Sandoz, Upsher Smith, Aurobindo, and Unichem.